共 50 条
Transcatheter versus surgical aortic valve replacement for severe aortic valve stenosis: Meta-analysis with trial sequential analysis
被引:0
|作者:
Jacquemyn, Xander
[1
]
Sa, Michel Pompeu
[2
,3
]
Rega, Filip
[1
,4
]
Verbrugghe, Peter
[1
,4
]
Meuris, Bart
[1
,4
]
Serna-Gallegos, Derek
[2
,3
]
Brown, James A.
[2
,3
]
Clavel, Marie-Annick
[5
,6
]
Pibarot, Philippe
[5
,6
]
Sultan, Ibrahim
[2
,3
]
机构:
[1] Katholieke Univ Leuven, Dept Cardiovasc Sci, Leuven, Belgium
[2] Univ Pittsburgh, Dept Cardiothorac Surg, Pittsburgh, PA USA
[3] Univ Pittsburgh, UPMC Heart & Vasc Inst, Med Ctr, 200 Lothrop St, Pittsburgh, PA 15213 USA
[4] Univ Hosp Leuven, Dept Cardiac Surg, Leuven, Belgium
[5] Ctr Rech Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada
[6] Univ Laval, Fac Med, Dept Med, Quebec City, PQ, Canada
关键词:
aortic valve replacement;
cardiac surgical procedures;
cardiovascular surgical procedures;
heart valve diseases;
heart valve prosthesis implantation;
meta-analysis;
D O I:
10.1016/j.jtcvs.2024.04.007
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Objectives: Randomized controlled trials comparing transcatheter aortic valve implantation with surgical aortic valve replacement demonstrate conflicting evidence, particularly in low-risk patients. We aim to reevaluate the evidence using trial sequential analysis, balancing type I and II errors, and compare with conventional meta-analysis. Methods: Databases were searched for randomized controlled trials, which were divided into higher-risk and lower-risk randomized controlled trials according to a pragmatic risk classification. Primary outcomes were death and a composite end point of death or disabling stroke assessed at 1 year and maximum followup. Conventional meta-analysis and trial sequential analysis were performed, and the required information size was calculated considering a type I error of 5% and a power of 90%. Results: Eight randomized controlled trials (n = 5274 higher-risk and 3661 lower- risk patients) were included. Higher-risk trials showed no significant reduction in death at 1 year with transcatheter aortic valve implantation (relative risk, 0.93, 95% CI, 0.81-1.08, P =.345). Lower-risk trials suggested lower death risk on conventional meta-analysis (relative risk, 0.67, 95% CI, 0.47-0.96, P = .031), but trial sequential analysis indicated potential spurious evidence (P = .116), necessitating more data for conclusive benefit (required information size = 5944 [59.8%]). For death or disabling stroke at 1 year, higher-risk trials lacked evidence (relative risk, 0.90, 95% CI, 0.79-1.02, P = .108). In lower-risk trials, transcatheter aortic valve implantation indicated lower risk in conventional meta-analysis (relative risk, 0.68, 95% CI, 0.50-0.93, P = .014), but trial sequential analysis suggested potential spurious evidence (P = .053), necessitating more data for conclusive benefit (required information size = 5122 [69.4%]). Follow-up results provided inconclusive evidence for both primary outcomes across risk categories. Conclusions: Conventional meta-analysis methods may have prematurely declared an early reduction of negative outcomes after transcatheter aortic valve implantation when compared with surgical aortic valve replacement. (J Thorac Cardiovasc Surg 2025;169:1214-25)
引用
收藏
页数:17
相关论文